Indian Pharma Products
- All
- News
- Videos
-
Amid Concern, Centre Plans Testing Drugs At Government Labs Before Export
Amid quality issues being raised globally for the cough syrups exported by Indian firms, the Centre is actively considering a proposal of testing drugs at government laboratories before they are dispatched to other countries.
-
"Someone Duplicated Cough Syrup": Indian Pharma After WHO Alert
After the WHO issued a product alert over India-made cough syrup in Marshal Islands and Micronesia, Managing Director, QP Pharma Chem Limited, Sudhir Pathak said that someone had duplicated the syrup to defame the Government of India.
-
Focus On Another India Pharma Firm After WHO Alert Over Contaminated Syrup
The World Health Organisation on Tuesday issued a product alert over contaminated syrup by an Indian manufacturer, warning that it is unsafe for use, especially in children, and may result in serious injury or death.
-
Indian Firm Suspends Production Of Eye Drops Linked To Death In US
The US Centers for Disease Control and Prevention (CDC) said it is testing unopened bottles of EzriCare Artificial Tears eye drops, manufactured by Chennai-based Global Pharma Healthcare.
-
Cough Syrup Deaths In Gambia Hits A Key Growth Area For India
Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.
-
DRDO Invites Applications From Indian Pharma Firms For Bulk Production Of Covid Drug 2-DG
The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer the technology to Indian pharmaceutical firms.
-
Wockhardt Makes Deal For Mystery Vaccine, Announcement In 2 Weeks
Indian pharma major Wockhardt is set to announce a major production deal for an undisclosed vaccine. The formal announcement is due in two weeks and the production of the vaccine will begin in October.
-
Amid Concern, Centre Plans Testing Drugs At Government Labs Before Export
Amid quality issues being raised globally for the cough syrups exported by Indian firms, the Centre is actively considering a proposal of testing drugs at government laboratories before they are dispatched to other countries.
-
"Someone Duplicated Cough Syrup": Indian Pharma After WHO Alert
After the WHO issued a product alert over India-made cough syrup in Marshal Islands and Micronesia, Managing Director, QP Pharma Chem Limited, Sudhir Pathak said that someone had duplicated the syrup to defame the Government of India.
-
Focus On Another India Pharma Firm After WHO Alert Over Contaminated Syrup
The World Health Organisation on Tuesday issued a product alert over contaminated syrup by an Indian manufacturer, warning that it is unsafe for use, especially in children, and may result in serious injury or death.
-
Indian Firm Suspends Production Of Eye Drops Linked To Death In US
The US Centers for Disease Control and Prevention (CDC) said it is testing unopened bottles of EzriCare Artificial Tears eye drops, manufactured by Chennai-based Global Pharma Healthcare.
-
Cough Syrup Deaths In Gambia Hits A Key Growth Area For India
Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.
-
DRDO Invites Applications From Indian Pharma Firms For Bulk Production Of Covid Drug 2-DG
The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer the technology to Indian pharmaceutical firms.
-
Wockhardt Makes Deal For Mystery Vaccine, Announcement In 2 Weeks
Indian pharma major Wockhardt is set to announce a major production deal for an undisclosed vaccine. The formal announcement is due in two weeks and the production of the vaccine will begin in October.
